Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
Identifieur interne : 001295 ( Main/Exploration ); précédent : 001294; suivant : 001296Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
Auteurs : Kyle M. Walker [Irlande (pays)] ; Janet PopeSource :
- Seminars in arthritis and rheumatism [ 1532-866X ] ; 2012.
Descripteurs français
- KwdFr :
- Algorithmes, Antagonistes alpha-adrénergiques (usage thérapeutique), Antagonistes des récepteurs aux angiotensines (usage thérapeutique), Association de médicaments, Enquêtes sur les soins de santé (), Humains, Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique), Inhibiteurs des canaux calciques (usage thérapeutique), Prise en charge de la maladie, Sclérodermie systémique (), Sclérodermie systémique (traitement médicamenteux), Échec thérapeutique.
- MESH :
- traitement médicamenteux : Sclérodermie systémique.
- usage thérapeutique : Antagonistes alpha-adrénergiques, Antagonistes des récepteurs aux angiotensines, Inhibiteurs de l'enzyme de conversion de l'angiotensine, Inhibiteurs des canaux calciques.
- Algorithmes, Association de médicaments, Enquêtes sur les soins de santé, Humains, Prise en charge de la maladie, Sclérodermie systémique, Échec thérapeutique.
English descriptors
- KwdEn :
- Adrenergic alpha-Antagonists (therapeutic use), Algorithms, Angiotensin Receptor Antagonists (therapeutic use), Angiotensin-Converting Enzyme Inhibitors (therapeutic use), Calcium Channel Blockers (therapeutic use), Disease Management, Drug Therapy, Combination, Health Care Surveys (statistics & numerical data), Humans, Scleroderma, Systemic (complications), Scleroderma, Systemic (drug therapy), Treatment Failure.
- MESH :
- chemical , therapeutic use : Adrenergic alpha-Antagonists, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers.
- complications : Scleroderma, Systemic.
- drug therapy : Scleroderma, Systemic.
- statistics & numerical data : Health Care Surveys.
- Algorithms, Disease Management, Drug Therapy, Combination, Humans, Treatment Failure.
Abstract
There is a need for standardization in systemic sclerosis (SSc) management.
DOI: 10.1016/j.semarthrit.2012.01.003
PubMed: 22464314
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000363
- to stream PubMed, to step Curation: 000363
- to stream PubMed, to step Checkpoint: 000344
- to stream Ncbi, to step Merge: 000172
- to stream Ncbi, to step Curation: 000172
- to stream Ncbi, to step Checkpoint: 000172
- to stream Main, to step Merge: 001296
- to stream Main, to step Curation: 001295
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.</title><author><name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name><affiliation wicri:level="1"><nlm:affiliation>Trinity College, Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Trinity College, Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Pope, Janet" sort="Pope, Janet" uniqKey="Pope J" first="Janet" last="Pope">Janet Pope</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22464314</idno><idno type="pmid">22464314</idno><idno type="doi">10.1016/j.semarthrit.2012.01.003</idno><idno type="wicri:Area/PubMed/Corpus">000363</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000363</idno><idno type="wicri:Area/PubMed/Curation">000363</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000363</idno><idno type="wicri:Area/PubMed/Checkpoint">000344</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000344</idno><idno type="wicri:Area/Ncbi/Merge">000172</idno><idno type="wicri:Area/Ncbi/Curation">000172</idno><idno type="wicri:Area/Ncbi/Checkpoint">000172</idno><idno type="wicri:Area/Main/Merge">001296</idno><idno type="wicri:Area/Main/Curation">001295</idno><idno type="wicri:Area/Main/Exploration">001295</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.</title><author><name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name><affiliation wicri:level="1"><nlm:affiliation>Trinity College, Dublin, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Trinity College, Dublin, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Pope, Janet" sort="Pope, Janet" uniqKey="Pope J" first="Janet" last="Pope">Janet Pope</name></author></analytic><series><title level="j">Seminars in arthritis and rheumatism</title><idno type="eISSN">1532-866X</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic alpha-Antagonists (therapeutic use)</term><term>Algorithms</term><term>Angiotensin Receptor Antagonists (therapeutic use)</term><term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term><term>Calcium Channel Blockers (therapeutic use)</term><term>Disease Management</term><term>Drug Therapy, Combination</term><term>Health Care Surveys (statistics & numerical data)</term><term>Humans</term><term>Scleroderma, Systemic (complications)</term><term>Scleroderma, Systemic (drug therapy)</term><term>Treatment Failure</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Algorithmes</term><term>Antagonistes alpha-adrénergiques (usage thérapeutique)</term><term>Antagonistes des récepteurs aux angiotensines (usage thérapeutique)</term><term>Association de médicaments</term><term>Enquêtes sur les soins de santé ()</term><term>Humains</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique)</term><term>Inhibiteurs des canaux calciques (usage thérapeutique)</term><term>Prise en charge de la maladie</term><term>Sclérodermie systémique ()</term><term>Sclérodermie systémique (traitement médicamenteux)</term><term>Échec thérapeutique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-Antagonists</term><term>Angiotensin Receptor Antagonists</term><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Calcium Channel Blockers</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Scleroderma, Systemic</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Scleroderma, Systemic</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Health Care Surveys</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Sclérodermie systémique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes alpha-adrénergiques</term><term>Antagonistes des récepteurs aux angiotensines</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term><term>Inhibiteurs des canaux calciques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Algorithms</term><term>Disease Management</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Treatment Failure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term><term>Association de médicaments</term><term>Enquêtes sur les soins de santé</term><term>Humains</term><term>Prise en charge de la maladie</term><term>Sclérodermie systémique</term><term>Échec thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is a need for standardization in systemic sclerosis (SSc) management.</div></front></TEI><affiliations><list><country><li>Irlande (pays)</li></country></list><tree><noCountry><name sortKey="Pope, Janet" sort="Pope, Janet" uniqKey="Pope J" first="Janet" last="Pope">Janet Pope</name></noCountry><country name="Irlande (pays)"><noRegion><name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001295 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001295 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22464314
|texte= Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22464314" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |